Minima stent system long-term safety study
Part of Genetic & congenital, Heart & circulation clinical trials.
This study checks the safety of the Minima Stent System over time. It is for people who need a stent to keep their blood vessel open. The study wants to see how the device works in real-world use.
Summary written for real people, not researchers, by Clin2.
Who can take part
- The patient or their legal guardian must agree to the study and sign a consent form.
- The patient must be approved for the Minima Stent System based on the device instructions.
- No active bloodstream infection needing antibiotics within the last 3 days before the procedure.
- No history of infection inside the heart (endocarditis) needing treatment in the last 6 months.
- No aneurysm (bulging weak spot) in the aorta or pulmonary artery where the stent will go.
- The patient must weigh at least 1.5 kg (about 3.3 pounds).
- The narrowed blood vessel must be the right size for the Minima stent balloon.
- No genetic condition known to cause blood vessel problems (like Williams syndrome or Loeys-Dietz syndrome).
- Only one blood vessel needs a stent during this procedure, not more than one.
- The patient cannot be in any other drug or device study right now.
- The patient is not expected to live less than 6 months due to other major diseases.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new minimally invasive procedure (placing a small stent) to improve blood flow to a severely threatened foot or lower leg. It may help people whose ulcers or gangrene are not treatable with standard bypass or other surgeries.
This study tracks the long-term safety and effectiveness of the Minos stent-graft system in treating abdominal aortic aneurysms. It collects data from patients across Europe and Asia to see how well the device works over five years.
This study tracks how well a newer heart stent (a small metal tube that keeps arteries open) works in real patients. Researchers want to understand if this specific stent design is safe and effective over time.
This trial tests a new type of stent (a small expandable tube) made of bioresorbable material that can dissolve over time. It's designed for young children who need treatment for narrowing in their aorta (main artery leaving the heart) or pulmonary artery (vessel to the lungs).
This trial tests a new type of stent (a small mesh tube) that slowly releases a medicine called sirolimus to keep your heart artery open after angioplasty. It is designed for people with narrowing in their heart arteries who need a stent.
This trial studies how well a minimally invasive (endovascular) procedure works over the long term for people with significant blockage in the lower aorta and iliac arteries. You may be considered if you need treatment for narrowing, re-narrowing, or a blockage of these arteries, and you can safely take the study medications and return for follow-ups.
Hear when a new Aortic Coarctation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.